Literature DB >> 12234026

Is LRIG1 a tumour suppressor gene at chromosome 3p14.3?

Håkan Hedman1, Jonas Nilsson, Dongsheng Guo, Roger Henriksson.   

Abstract

The LRIG1 gene (formerly LIG-1), recently cloned by us, displays structural similarities to the Drosophila Kek I gene. Kek I encodes a cell surface protein, Kekkon-1, which inhibits epidermal growth factor receptor-mediated signalling. We localized the LRIG1 gene to chromosome band 3p14.3, a region known to be deleted in various human cancers. In the present study LRIG1 gene expression was examined in different tumour cell lines and corresponding normal tissues by real-time RT-PCR. In many tumour cell lines, LRIG1 expression appeared absent or was down regulated compared to corresponding normal tissues. The results are consistent with LRIG1 being a tumour suppressor gene in humans. However, further studies are justified to elucidate the explicit role of LRIG1 as a negative regulator of oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234026     DOI: 10.1080/028418602760169398

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  42 in total

1.  Effects of RNAi-mediated gene silencing of LRIG3 expression on cell cycle and survival of glioma cells.

Authors:  Mingjun Cai; Ruifan Xie; Lin Han; Rudong Chen; Baofeng Wang; Fei Ye; Dongsheng Guo; Ting Lei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

2.  LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy.

Authors:  David L Shattuck; Jamie K Miller; Melanie Laederich; Melanie Funes; Heidi Petersen; Kermit L Carraway; Colleen Sweeney
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

3.  Effect of silencing LRIG3 gene on the proliferation and apoptosis of bladder cancer T24 cells.

Authors:  Xiaoyi Yuan; Shixin Bao; Weimin Yang; Zhangqun Ye
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-04-20

Review 4.  The LRIG family: enigmatic regulators of growth factor receptor signaling.

Authors:  Catalina Simion; Maria Elvira Cedano-Prieto; Colleen Sweeney
Journal:  Endocr Relat Cancer       Date:  2014-09-02       Impact factor: 5.678

5.  Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field.

Authors:  Fernanda Ledda; Gustavo Paratcha
Journal:  Biomark Insights       Date:  2007-02-14

6.  Vertebrate Lrig3-ErbB interactions occur in vitro but are unlikely to play a role in Lrig3-dependent inner ear morphogenesis.

Authors:  Victoria E Abraira; Takunori Satoh; Donna M Fekete; Lisa V Goodrich
Journal:  PLoS One       Date:  2010-02-01       Impact factor: 3.240

7.  Over-expression of LRIG1 suppresses biological function of pituitary adenoma via attenuation of PI3K/AKT and Ras/Raf/ERK pathways in vivo and in vitro.

Authors:  Shi-Qi Cheng; Heng-Yi Fan; Xin Xu; Wei-Wei Gao; Shi-Gang Lv; Min-Hua Ye; Miao-Jing Wu; Xiao-Li Shen; Zu-Jue Cheng; Xin-Gen Zhu; Yan Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

Review 8.  Mechanisms of ErbB receptor negative regulation and relevance in cancer.

Authors:  William H D Fry; Lakmal Kotelawala; Colleen Sweeney; Kermit L Carraway
Journal:  Exp Cell Res       Date:  2008-07-31       Impact factor: 3.905

9.  A genome assembly-integrated dog 1 Mb BAC microarray: a cytogenetic resource for canine cancer studies and comparative genomic analysis.

Authors:  R Thomas; S E Duke; E K Karlsson; A Evans; P Ellis; K Lindblad-Toh; C F Langford; M Breen
Journal:  Cytogenet Genome Res       Date:  2008-12-18       Impact factor: 1.636

10.  Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL).

Authors:  Katy Hanlon; Claudius E Rudin; Lorna W Harries
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.